论著

孕期不同甲状腺功能状态血清高密度脂蛋白胆固醇和载脂蛋白A-Ⅰ的变化趋势

  • 蔡佳 ,
  • 张曼
展开
  • (首都医科大学附属北京世纪坛医院检验科,尿液细胞分子诊断北京市重点实验实,北京100038)

网络出版日期: 2015-12-18

基金资助

国家高技术研究发展计划(863计划,2014AA022304)和尿液细胞分子诊断北京市重点实验室基金(Z151100001615060)资助

Variation tendency in serum high density lipoprotein cholesterol and apolipopro-tein A-Ⅰ in different thyroid function status during pregnancy

  • CAI Jia ,
  • ZHANG Man
Expand
  • (Department of Clinical Laboratory, Beijing Shijitan Hospital, Capital Medical University,Beijing Key Laboratory of Urinary Cellular Molecular Diagnostics, Beijing 100038, China.)

Online published: 2015-12-18

Supported by

Supported by the National High Technology Research and Development Program of China (863 Program, 2014AA022304) and Beijing Key Laboratory of Urinary Cellular Molecular Diagnostics (Z151100001615060)

摘要

目的:研究不同甲状腺功能状态对孕妇血清高密度脂蛋白胆固醇(high density cholesterol, HDL-C)和载脂蛋白A-Ⅰ(apolipoprotein A-Ⅰ, ApoA-Ⅰ)代谢的影响。方法:采集30名甲状腺功能正常(正常组)、19名亚临床甲状腺功能减退(亚甲减组)及8名亚临床甲状腺功能亢进(亚甲亢组)孕妇孕9~12、 14~17、 23~26和37~40周的空腹血清标本,测其血清HDL-C和ApoA-Ⅰ含量。采用重复测量数据方差分析的秩和检验分析4个妊娠时段孕妇血清HDL-C、ApoA-Ⅰ含量的变化;采用一般线性模型(general linear model, GLM)分析3组孕妇孕期血清HDL-C、ApoA-Ⅰ含量的差异。结果:孕期各组孕妇血清HDL-C含量的变化差异均无统计学意义(χ2=5.428,P=0.143; χ2=2.027,P=0.567; χ2=2.885,P=0.410),正常孕妇和亚甲减孕妇血清ApoA-Ⅰ的含量增高,差异均有统计学意义(χ2=46.343,P<0.001; χ2=35.984,P<0.001),亚甲亢孕妇血清ApoA-Ⅰ含量的变化差异无统计学意义(χ2=6.750,P=0.080)。亚甲亢孕妇孕期血清HDL-C和ApoA-Ⅰ的含量均低于正常孕妇,差异均有统计学意义(P=0.025,P=0.027),正常孕妇与亚甲减孕妇孕期血清HDL-C和ApoA-Ⅰ含量的差异均无统计学意义(P =0.378,P =0.549)。结论:妊娠期亚甲亢影响孕妇血清HDL-C和ApoA-Ⅰ代谢,进而影响胎儿的生长发育;妊娠期亚甲减(经优甲乐治疗后)未发现影响孕妇血清HDL-C和ApoA-Ⅰ代谢。

本文引用格式

蔡佳 , 张曼 . 孕期不同甲状腺功能状态血清高密度脂蛋白胆固醇和载脂蛋白A-Ⅰ的变化趋势[J]. 北京大学学报(医学版), 2015 , 47(6) : 910 -913 . DOI: 10.3969/j.issn.1671167X.2015.06.004

Abstract

Objective:To study the metabolism of high density lipoprotein cholesterol (HDL-C) and apolipoprotein A-Ⅰ (ApoA-Ⅰ) in different thyroid function status during pregnancy. Methods:This study recruited thirty cases of euthyroid, with nineteen cases of subclinical hypothyroid and eight cases of subclinical hyperthyroid pregnancy. The concentrations of fasting serum HDL-C and ApoA-Ⅰ were detected and analyzed from 9-12, 14-17, 23-26, and 37-40 gestational weeks. Friedman repeated measures ANOVA on ranks was adopted to analyze the changes of serum HDL-C and ApoA-Ⅰ at different stages. General linear model (GLM) was adopted to analyze the differences of serum HDL-C and ApoA-Ⅰ in different thyroid function status during pregnancy.Results:There were no significant differences of maternal serum HDL-C among different stages (χ2=5.428,P=0.143, χ2=2.027,P=0.567, χ2=2.885,P=0.410). There were significant differences of serum ApoA-Ⅰ during euthyroid and subclinical hypothyroid pregnancies (χ2=46.343, P<0.001, χ2=35.984, P<0.001), and no significant difference during subclinical hyperthyroid pregnancy (χ2=6.750, P=0.080). There were significant differences of serum HDL-C and ApoA-Ⅰ between euthyroid and subclinical hyperthyroid pregnancies (P=0.025,P=0.027), and no significant differences between euthyroid and subclinical hypothyroid pregnancies (P=0.378,P=0.549). Conclusion:Subclinical hyperthyroidism affected the metabolism of maternal serum HDL-C and ApoA-Ⅰ, which could affect the fetal growth and development. Subclinical hypothyroidism (after treatment with drugs) had no obvious effect on the metabolism of maternal serum HDL-C and ApoA-Ⅰ.

文章导航

/